OPTIMIZING AND RAPIDLY TRANSLATING A NOVEL CANCER TREATMENT STRATEGY THAT RATIONALLY COMBINES MTOR INHIBITORS AND IMMUNOTHERAPY
Principal Investigator(s)
Curiel,Tyler J
Funded by
MIKE HOGG FUND
Research Start Date
Status
Inactive